Therese Sørlie
Therese Sørlie
Dep. of Cancer Genetics, Inst. for Cancer Research, Oslo University Hospital
Verified email at - Homepage
Cited by
Cited by
Molecular portraits of human breast tumours
CM Perou, T Sørlie, MB Eisen, M Van De Rijn, SS Jeffrey, CA Rees, ...
nature 406 (6797), 747-752, 2000
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sørlie, CM Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, ...
Proceedings of the National Academy of Sciences 98 (19), 10869-10874, 2001
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
JR Pollack, T Sørlie, CM Perou, CA Rees, SS Jeffrey, PE Lonning, ...
Proceedings of the National Academy of Sciences 99 (20), 12963-12968, 2002
Database of p53 gene somatic mutations in human tumors and cell lines.
M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sørlie, E Hovig, ...
Nucleic acids research 22 (17), 3551, 1994
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang, DSA Nuyten, JB Sneddon, T Hastie, R Tibshirani, T Sørlie, ...
Proceedings of the national academy of sciences 102 (10), 3738-3743, 2005
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer
A Bergamaschi, YH Kim, P Wang, T Sørlie, T Hernandez‐Boussard, ...
Genes, Chromosomes and Cancer 45 (11), 1033-1040, 2006
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities
T Sørlie
European journal of cancer 40 (18), 2667-2675, 2004
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
T Sørlie, Y Wang, C Xiao, H Johnsen, B Naume, RR Samaha, ...
BMC genomics 7, 1-15, 2006
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
A Bergamaschi, E Tagliabue, T Sørlie, B Naume, T Triulzi, R Orlandi, ...
The Journal of pathology 214 (3), 357-367, 2008
Gene expression patterns in ovarian carcinomas
ME Schaner, DT Ross, G Ciaravino, T Sørlie, O Troyanskaya, M Diehn, ...
Molecular biology of the cell 14 (11), 4376-4386, 2003
Triple-negative breast cancer: present challenges and new perspectives
F Podo, LMC Buydens, H Degani, R Hilhorst, E Klipp, IS Gribbestad, ...
Molecular oncology 4 (3), 209-229, 2010
Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression
IO Potapenko, VD Haakensen, T Lüders, Å Helland, I Bukholm, T Sørlie, ...
Molecular oncology 4 (2), 98-118, 2010
Cell-type-specific responses to chemotherapeutics in breast cancer
MA Troester, KA Hoadley, T Sørlie, BS Herbert, AL Børresen-Dale, ...
Cancer research 64 (12), 4218-4226, 2004
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
AA Muggerud, JA Rønneberg, F Wärnberg, J Botling, F Busato, ...
Breast Cancer Research 12, 1-10, 2010
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
VN Kristensen, CJ Vaske, J Ursini-Siegel, P Van Loo, SH Nordgard, ...
Proceedings of the National Academy of Sciences 109 (8), 2802-2807, 2012
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
HG Russnes, HKM Vollan, OC Lingjærde, A Krasnitz, P Lundin, B Naume, ...
Science translational medicine 2 (38), 38ra47-38ra47, 2010
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer
T Sørlie, CM Perou, C Fan, S Geisler, T Aas, A Nobel, G Anker, LA Akslen, ...
Molecular cancer therapeutics 5 (11), 2914-2918, 2006
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
X Tekpli, T Lien, AH Røssevold, D Nebdal, E Borgen, HO Ohnstad, ...
Nature communications 10 (1), 5499, 2019
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
B Naume, X Zhao, M Synnestvedt, E Borgen, HG Russnes, OC Lingjærde, ...
Molecular oncology 1 (2), 160-171, 2007
Re-definition of claudin-low as a breast cancer phenotype
C Fougner, H Bergholtz, JH Norum, T Sørlie
Nature communications 11 (1), 1787, 2020
The system can't perform the operation now. Try again later.
Articles 1–20